Citadel Advisors - AQUINOX PHARMACEUTICALS INC ownership

AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 52 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AQUINOX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$30,000
-80.5%
10,963
-84.6%
0.00%
Q4 2018$154,000
-86.7%
71,149
-82.0%
0.00%
Q3 2018$1,157,000
+7.5%
395,018
-2.8%
0.00%
Q2 2018$1,076,000
+120.9%
406,264
+1074.2%
0.00%
Q1 2018$487,000
+289.6%
34,600
+224.3%
0.00%
Q4 2017$125,000
-35.6%
10,669
-22.1%
0.00%
Q3 2017$194,00013,6880.00%
Other shareholders
AQUINOX PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Prosight Management, LP 400,900$1,062,0000.78%
EMORY UNIVERSITY 209,207$554,0000.37%
EcoR1 Capital, LLC 1,150,000$3,048,0000.29%
Baker Brothers Advisors 10,934,154$28,976,0000.22%
DLD Asset Management, LP 763,100$2,030,0000.15%
UNIVERSITY OF NOTRE DAME DU LAC 214,759$569,0000.11%
Kalos Management, Inc. 15,850$226,0000.10%
SPHERA FUNDS MANAGEMENT LTD. 257,613$683,0000.09%
DLD Asset Management, LP 379,900$1,007,0000.08%
DLD Asset Management, LP 379,300$1,009,0000.08%
View complete list of AQUINOX PHARMACEUTICALS INC shareholders